FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
AdvisorShares Psychedelics ETF ETF AnalysisComprehensive ETF analysis for AdvisorShares Psychedelics ETF (PSIL) including NAV, expense ratio, sector breakdown, and holdings data.ETF AnalysisPSIL
PSIL
AdvisorShares Psychedelics ETF
PSIL
  1. Home
  2. Screener
  3. AdvisorShares Psychedelics ETFPSILETF
AdvisorShares Psychedelics ETF Logo

AdvisorShares Psychedelics ETF

ETF
🇺🇸PSIL•AMEX•Equity

Your view on PSIL

AdvisorShares Psychedelics ETF Logo

AdvisorShares Psychedelics ETF

ETFAdvisorShares
🇺🇸PSIL•AMEX•Equity
AUM (USD)$58.12M
Expense Ratio1.84%
Holdings25

Sentiment

AUM (USD)

$58.12M

Expense Ratio

1.84%

Holdings

25

Sentiment

PSIL
AdvisorShares Psychedelics ETF
PSIL

Overview for AdvisorShares Psychedelics ETF

Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL
Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL
Fund Type
ETF
Fund Issuer
AdvisorShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
September 15, 2021
Domicile
US
Website
advisorshares.com/etfs/PSIL

About this fund

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from …

PSIL Stock Price

Key Facts

Equity

Expense Ratio

1.84%

AUM

$58.12M

Fund Details

NAV$25.05 USD
Holdings25
Average Volume41.2K
Inception DateSeptember 15, 2021
Asset ClassEquity
Fund IssuerAdvisorShares
DomicileUS
ISINUS00768Y2972
CUSIP00768Y297
NAV CurrencyUSD

Expense Ratio

1.84%

Assets Under Management

$58.12M

NAV

$25.05 USD

Holdings

25

Average Volume

41.2K

Inception Date

September 15, 2021

Asset Class

Equity

Fund Issuer

AdvisorShares

Domicile

US

ISIN

US00768Y2972

CUSIP

00768Y297

NAV Currency

USD

Expense Ratio

1.84%

Assets Under Management

$58.12M

NAV

$25.05 USD

Holdings

25

Average Volume

41.2K

Inception Date

September 15, 2021

Asset Class

Equity

Fund Issuer

AdvisorShares

Domicile

US

ISIN

US00768Y2972

CUSIP

00768Y297

NAV Currency

USD

Data last updated: Sep 16, 2026, 07:11 AM

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

News

Latest Market News

What is PSIL?

AdvisorShares Psychedelics ETF (PSIL) is a Equity fund from AdvisorShares, listed since 2021, with $58.1M in assets under management, a 1.84% expense ratio, a NAV of $25.05 USD.

What's in PSIL? Top 10 holdings

HoldingWeight
Definium Therapeutics, Inc DFTX11.66%
Compass Pathways PLC CMPS11.15%
Helus Pharma INC HELP8.82%
Neurocrine Biosciences INC NBIX4.93%
Abbvie INC ABBV4.82%
Eli Lilly & Co LLY4.78%
Relmada Therapeutics INC RLMD4.65%
Nrx Pharmaceuticals INC NRXP4.60%
Gh Research PLC GHRS4.37%
Johnson & Johnson JNJ4.35%

PSIL sector breakdown

  • Healthcare 100.00%

Comparable funds

  • APRZTrueShares Structured Outcome (April) ETF
  • ARMGLeverage Shares 2x Long ARM Daily ETF
  • BOEUDirexion Daily BA Bull 2X Shares
  • DUKQOcean Park Domestic ETF
  • GUMIGoldman Sachs Ultra Short Municipal Income ETF
  • MULTFranklin Multisector Income ETF
  • PSFOPacer Swan SOS Flex (October) ETF

More AdvisorShares ETFs

  • MSOSAdvisorShares Pure US Cannabis ETF
  • MSOXAdvisorShares MSOS Daily Leveraged ETF
  • QPXAdvisorShares Q Dynamic Growth ETF
  • SUREAdvisorShares Insider Advantage ETF
  • VEGASTAR GLOBAL BUY-WRITE ETF
  • YOLOAdvisorShares Pure Cannabis ETF
  • AADRDORSEY WRIGHT ADR ETF
  • CWSAdvisorShares Focused Equity ETF
  • DWAWAdvisorShares Dorsey Wright FSM All Cap World Equity ETF
  • DWSHAdvisorShares Dorsey Wright Short ETF
  • DWUSAdvisorShares Dorsey Wright FSM U.S. Core ETF
  • GKAdvisorShares Gerber Kawasaki ETF